Abstract
Historical and most currently held views of microbial pathogenesis and virulence are plagued by confusing and imprecise terminology and definitions that require revision and exceptions to accommodate new basic science and clinical information about microbes and infectious diseases. These views are also inherently unable to account for the ability of some microbes to cause disease in certain, but not other hosts, because they are grounded in singular, either microbe-or host-centric views. The damage-response framework is an integrated theory of microbial pathogenesis that puts forth the view that microbial pathogenesis reflects the outcome of an interaction between a host and a microbe, with each entiry contributing to the nature of the outcome, which in turn depends on the amount of host damage that results from the host-microbe interaction. This view is able to accommodate new information and explain why infection with the same microbe can have different outcomes in different hosts. This chapter describes the origins and conceptual underpinnings of and the outcomes of infection put forth in, the damage-response framework.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Casadevall A, Pirofski L. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 1999;67:3703–13.
Casadevall A, Pirofski L. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 2003; 1:17–24.
Pirofski L, Casadevall A. The meaning of microbial exposure, infection, colonisation and disease in clinical practice. Lancet Infect Dis 2002; 2(10):628–35.
Rangel-Frausto MS, Wiblin T, Blumberg HM et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29:253–8.
Blumberg HM, Jarvis WR, Soucie JM et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33(2):177–86.
Spellberg B, Powers JH, Brass EP et al. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004; 38(9):1279–86.
Armstrong D. History of opportunistic infection in the immunocompromised host. Clin Infect Dis 1993; 17 (suppl): S318–S321.
Casadevall A, Pirofski LA. What is a pathogen? Ann Med 2002; 34(1):2–4.
Casadevall A, Pirofski L. Host-pathogen interactions: the attributes of virulence. J Infect Dis 2001; 184:337–45.
Casadevall A, Pirofski L. Host-pathogen interactions. II. The basic concepts of microbial commensalism, colonization, infection and disease. Infect Immun 2000; 68:6511–8.
Dethlefsen L, Eckburg PB, Bik Em et al. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006.
Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 2005; 308(5728):1635–8.
Palmer C, Bik EM, Eisen MB et al. Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res 2006; 34(1) e5.
Mutch DM, Simmering R, Donnicola D et al. Impact of commensal microbiota on murine gastrointestinal tract gene ontologies. Physiol Genomics 2004; 19(1):22–31.
Mazmanian SK, Liu CH, Tzianabos AO et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122(1):107–18.
Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004; 12(12):562–8.
Bufford JD, Gern JE. The hygiene hypothesis revisited. Immunol Allergy Clin North Am 2005; 25(2):247–vi.
Kitagaki K, Businga TR, Racila D et al. Intestinal helminths protect in a murine model of asthma. J Immunol 2006; 177(3):1628–35.
Anlar FY, Kabasakal E, Karsi R. Tuberculosis and atopy: a study in an endemic area. Respir Med 2006; 100(9):1647–50.
Casadevall A, Pirofski LA. The weapon potential of a microbe. Trends Microbiol 2004; 12(6):259–63.
Casadevall A, Pirofski L. Fungi as biological weapons. Med Mycol 2006; In press.
Pirofski L, Casadevall A. Immunomodulators as an antimicrobial tool. Curr Opin Microbiol 2006; In press.
Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation. Treating infectious diseases in a microbial world: Report of two workshops on novel antimicrobial therapies. Washington, DC: National Academies Press, 2006.
Casadevall A, Pirofski L. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Advances Immunol 2006; In press.
Goldman DL, Davis J, Bommarito F et al. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. J Infect Dis 2006; 193(8):1178–86.
Anderson CC, Marzinger P. Danger: the view from the cliff. Semin Immunol 2000; 12:231–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Pirofski, La., Casadevall, A. (2008). The Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases. In: Huffnagle, G.B., Noverr, M.C. (eds) GI Microbiota and Regulation of the Immune System. Advances in Experimental Medicine and Biology, vol 635. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09550-9_11
Download citation
DOI: https://doi.org/10.1007/978-0-387-09550-9_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79989-6
Online ISBN: 978-0-387-09550-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)